宿主因子TIMP1在严重感染后维持长期的髓质偏差造血
Tengfei Song1, Yonghong Yao1, Julien Papoin1
1Institute of Molecular Medicine, Feinstein Institutes for Medical Research , Manhasset, NY, USA.
The Journal of experimental medicine
|October 18, 2023
概括
严重的感染通过增加金属蛋白酶1 (TIMP1) 的组织抑制剂1 (TIMP1) 来增强长期髓状细胞的产生. 在病原体被清除后,这维持了免疫细胞的产生,为造血干细胞和原始细胞命运提供了治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 感染可以通过持续的髓质输出来增强先天免疫力.
- 感染后的长期髓状细胞生成的确切机制尚不清楚.
研究的目的:
- 为了研究导致严重感染后持续性骨髓形成的分子机制.
- 确定调节造血干细胞和原生细胞 (HSPC) 命运的潜在治疗点.
主要方法:
- 使用小鼠多微生物腹膜炎 (败血症) 模型.
- 在感染后的小鼠中分析了骨髓形成和基因表达.
- 研究了金属蛋白酶1 (TIMP1) 组织抑制剂的作用及其与ADAM10和Notch信号的相互作用.
主要成果:
- 严重的感染诱导增长和持续的骨髓形成后解决.
- 在感染后的小鼠中,金属蛋白酶1 (TIMP1) 组织抑制剂的构成性上调.
- TIMP1对抗ADAM10,从而抑制Notch信号传递并促进骨髓形成.
结论:
- TIMP1充当了过去感染的分子记者,维持了超骨髓形成.
- 在感染后的免疫调节中,TIMP1起着至关重要的作用.
- TIMP1代表了调节HSPC细胞命运的潜在治疗标.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K


